{"DataElement":{"publicId":"3474988","version":"1","preferredName":"Gynecologic Uterine Sarcoma Tumor Federation of Gynecology and Obstetrics Gynecologic (FIGO) 2009 Stage","preferredDefinition":"Anatomic extent of the primary uterine sarcoma based on surgical pathologic examination.","longName":"3474942v1.0:3474964v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3474942","version":"1","preferredName":"Gynecologic Neoplasm Uterine Corpus Sarcoma Stage","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A malignant mesenchymal tumor arising from the wall of the uterine corpus (uterine body).  The most representative examples are leiomyosarcoma and endometrial stromal sarcoma. -- 2004_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"2206690v1.0:3474940v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2206690","version":"1","preferredName":"Gynecologic Neoplasm","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C28016:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gynecologic","conceptCode":"C28016","definition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0016-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3474940","version":"1","preferredName":"Uterine Corpus Sarcoma Stage","preferredDefinition":"A malignant mesenchymal tumor arising from the wall of the uterine corpus (uterine body).  The most representative examples are leiomyosarcoma and endometrial stromal sarcoma. -- 2004:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C6339:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Sarcoma","conceptCode":"C6339","definition":"A malignant mesenchymal neoplasm arising from the wall of the uterine corpus (uterine body).  The most representative examples are leiomyosarcoma and endometrial stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BDB14A-1AC7-57D2-E040-BB89AD437301","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BDB14A-1AD8-57D2-E040-BB89AD437301","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per request by D.Reeves. mc 6/5/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3474964","version":"1","preferredName":"Uterine Corpus Sarcoma Federation of Gynecology and Obstetrics (FIGO) 2009 Stage","preferredDefinition":"A malignant mesenchymal tumor arising from the wall of the uterine corpus (uterine body).  The most representative examples are leiomyosarcoma and endometrial stromal sarcoma. -- 2004_An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies._A number with no fractional part, including the negative and positive numbers as well as zero.::2009_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3474964v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IB","valueDescription":"Adenosarcoma pT1b TNM Finding v7","ValueMeaning":{"publicId":"3447058","version":"1","preferredName":"Adenosarcoma pT1b TNM Finding v7","longName":"3447058","preferredDefinition":"Tumor invades to less than half of the myometrium. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT1b TNM Finding v7","conceptCode":"C89613","definition":"Tumor invades to less than half of the myometrium. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-322A-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E05B-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"I","valueDescription":"Adenosarcoma pT1 TNM Finding v7","ValueMeaning":{"publicId":"3447054","version":"1","preferredName":"Adenosarcoma pT1 TNM Finding v7","longName":"3447054","preferredDefinition":"Tumor limited to the uterus. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT1 TNM Finding v7","conceptCode":"C89611","definition":"Tumor limited to the uterus. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-31DE-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E033-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IA","valueDescription":"Adenosarcoma pT1a TNM Finding v7","ValueMeaning":{"publicId":"3447056","version":"1","preferredName":"Adenosarcoma pT1a TNM Finding v7","longName":"3447056","preferredDefinition":"Tumor limited to endometrium/endocervix. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT1a TNM Finding v7","conceptCode":"C89612","definition":"Tumor limited to endometrium/endocervix. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-3204-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E047-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IC","valueDescription":"Adenosarcoma pT1c TNM Finding v7","ValueMeaning":{"publicId":"3447060","version":"1","preferredName":"Adenosarcoma pT1c TNM Finding v7","longName":"3447060","preferredDefinition":"Tumor invades more than half of the myometrium. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT1c TNM Finding v7","conceptCode":"C89614","definition":"Tumor invades more than half of the myometrium. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-3250-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E06F-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"II","valueDescription":"Adenosarcoma pT2 TNM Finding v7","ValueMeaning":{"publicId":"3447062","version":"1","preferredName":"Adenosarcoma pT2 TNM Finding v7","longName":"3447062","preferredDefinition":"Tumor extends beyond the uterus, within the pelvis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT2 TNM Finding v7","conceptCode":"C89615","definition":"Tumor extends beyond the uterus, within the pelvis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-3276-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E083-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Adenosarcoma pT2a TNM Finding v7","ValueMeaning":{"publicId":"3447064","version":"1","preferredName":"Adenosarcoma pT2a TNM Finding v7","longName":"3447064","preferredDefinition":"Tumor involves adnexa. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT2a TNM Finding v7","conceptCode":"C89616","definition":"Tumor involves adnexa. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-329C-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E097-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Adenosarcoma pT2b TNM Finding v7","ValueMeaning":{"publicId":"3447066","version":"1","preferredName":"Adenosarcoma pT2b TNM Finding v7","longName":"3447066","preferredDefinition":"Tumor involves other pelvic tissues. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT2b TNM Finding v7","conceptCode":"C89617","definition":"Tumor involves other pelvic tissues. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-32C2-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E0AB-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"III","valueDescription":"Adenosarcoma pT3 TNM Finding v7","ValueMeaning":{"publicId":"3447068","version":"1","preferredName":"Adenosarcoma pT3 TNM Finding v7","longName":"3447068","preferredDefinition":"Tumor involves abdominal tissues. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT3 TNM Finding v7","conceptCode":"C89618","definition":"Tumor involves abdominal tissues. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-32E8-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E0BF-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Adenosarcoma pT3a TNM Finding v7","ValueMeaning":{"publicId":"3447070","version":"1","preferredName":"Adenosarcoma pT3a TNM Finding v7","longName":"3447070","preferredDefinition":"Tumor involves abdominal tissues, one site. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT3a TNM Finding v7","conceptCode":"C89619","definition":"Tumor involves abdominal tissues, one site. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-330E-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E0D3-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Adenosarcoma pT3b TNM Finding v7","ValueMeaning":{"publicId":"3447072","version":"1","preferredName":"Adenosarcoma pT3b TNM Finding v7","longName":"3447072","preferredDefinition":"Tumor invades abdominal tissues, more than one site. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT3b TNM Finding v7","conceptCode":"C89620","definition":"Tumor invades abdominal tissues, more than one site. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-3334-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E0E7-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IV","valueDescription":"Adenosarcoma pT4 TNM Finding v7","ValueMeaning":{"publicId":"3447074","version":"1","preferredName":"Adenosarcoma pT4 TNM Finding v7","longName":"3447074","preferredDefinition":"Tumor invades bladder or rectum. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosarcoma pT4 TNM Finding v7","conceptCode":"C89621","definition":"Tumor invades bladder or rectum. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF0DCE12-335A-ACD4-E040-BB89AD4321A1","latestVersionIndicator":"Yes","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEB10F-E0FB-A584-E040-BB89AD433EC2","beginDate":"2012-05-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3474963","version":"1","preferredName":"Uterine Corpus Sarcoma Federation of Gynecology and Obstetrics Integer::2009 Stage","preferredDefinition":"A malignant mesenchymal tumor arising from the wall of the uterine corpus (uterine body).  The most representative examples are leiomyosarcoma and endometrial stromal sarcoma. -- 2004:An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology.  They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.:A number with no fractional part, including the negative and positive numbers as well as zero.::2009:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3474963v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Sarcoma","conceptCode":"C6339","definition":"A malignant mesenchymal neoplasm arising from the wall of the uterine corpus (uterine body).  The most representative examples are leiomyosarcoma and endometrial stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Federation of Gynecology and Obstetrics","conceptCode":"C89808","definition":"An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BEB10F-E000-A584-E040-BB89AD433EC2","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BEB10F-E011-A584-E040-BB89AD433EC2","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"COOPERM","dateModified":"2012-06-05","changeDescription":"Created for CRF standard harmonization. Released per request by D.Reeves. mc 6/5/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3444895","version":"1","longName":"Corpus Uteri Sarcoma","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000586","version":"1","longName":"FIGO","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"},{"publicId":"10000585","version":"1","longName":"FIGO","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"FIGO Stage","type":"Preferred Question Text","description":"FIGO Stage","url":null,"context":"NCI Standards"}],"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"C1BEB10F-E14E-A584-E040-BB89AD433EC2","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per request by D.Reeves. mc 6/5/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}